The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study).

Diabetes Care · 2011 · PMC3041176 · PMID 21266648

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantP < 0.001actually significant

The difference in HbA 1c reduction was highly significant ( P < 0.001) between G1 and G2 (0.67% [0.35–0.99]) or G3 (0.91% [0.60–1.21]), but not between G2 and G3 ( Fig. 2 B and Supplementary Table 2 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.